 | • レポートコード：QAF27670 • 出版社/出版日：QYResearch / 2021年4月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、149ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の好酸球性食道炎治療薬市場について種類別（ブデソニド、フルチカゾン、その他）、用途別（病院、診療所、ドラッグストア）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・好酸球性食道炎治療薬市場の概要 ・世界の主要地域別好酸球性食道炎治療薬市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の好酸球性食道炎治療薬市場規模2016-2021：種類別（ブデソニド、フルチカゾン、その他） ・世界の好酸球性食道炎治療薬市場予測2012-2027：種類別（ブデソニド、フルチカゾン、その他） ・世界の好酸球性食道炎治療薬市場規模2016-2021：用途別（病院、診療所、ドラッグストア） ・世界の好酸球性食道炎治療薬市場予測2012-2027：用途別（病院、診療所、ドラッグストア） ・好酸球性食道炎治療薬のアメリカ市場規模と予測2016-2021 ・好酸球性食道炎治療薬のヨーロッパ市場規模と予測2016-2021 ・好酸球性食道炎治療薬の中国市場規模と予測2016-2021 ・好酸球性食道炎治療薬の日本市場規模と予測2016-2021 ・好酸球性食道炎治療薬の東南アジア市場規模と予測2016-2021 ・好酸球性食道炎治療薬のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （AstraZeneca、GSK、Bayer、Adare Pharmaceuticals、DBV Technologies、Dr. Falk Pharma、Quorum Innovations、Takeda、Calypso、Celgene、Regeneron） ・好酸球性食道炎治療薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・好酸球性食道炎治療薬の市場動向・機会・課題 ・調査の結論 |
Eosinophilic esophagitis (EoE, also spelled eosinophilic oesophagitis), also known as allergic oesophagitis, is an allergic inflammatory condition of the esophagus that involves eosinophils, a type of white blood cell. Symptoms are swallowing difficulty, food impaction, vomiting, and heartburn.
Eosinophilic esophagitis was first described in children but also occurs in adults. The condition is not well understood, but food allergy may play a significant role. The treatment may consist of removal of known or suspected triggers and medication to suppress the immune response.
This report studies the eosinophilic esophagitis drug market.
The classification of eosinophilic esophagitis drug includes budesonide, fluticasone and other types, and the proportion of budesonide in 2017 is about 52%.
Market Analysis and Insights: Global Eosinophilic Esophagitis Drug Market
The global Eosinophilic Esophagitis Drug market was valued at US$ 129.8 in 2020 and will reach US$ 178.9 million by the end of 2027, growing at a CAGR of 5.5% during 2022-2027.
Global Eosinophilic Esophagitis Drug Scope and Market Size
The global Eosinophilic Esophagitis Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Eosinophilic Esophagitis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Budesonide
Fluticasone
Others
Segment by Application
Hospitals
Clinics
Drugstore
The Eosinophilic Esophagitis Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Eosinophilic Esophagitis Drug market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
AstraZeneca
GSK
Bayer
Adare Pharmaceuticals
DBV Technologies
Dr. Falk Pharma
Quorum Innovations
Takeda
Calypso
Celgene
Regeneron
1 Eosinophilic Esophagitis Drug Market Overview
1.1 Eosinophilic Esophagitis Drug Product Scope
1.2 Eosinophilic Esophagitis Drug Segment by Type
1.2.1 Global Eosinophilic Esophagitis Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 Budesonide
1.2.3 Fluticasone
1.2.4 Others
1.3 Eosinophilic Esophagitis Drug Segment by Application
1.3.1 Global Eosinophilic Esophagitis Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Drugstore
1.4 Eosinophilic Esophagitis Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Eosinophilic Esophagitis Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Eosinophilic Esophagitis Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Eosinophilic Esophagitis Drug Price Trends (2016-2027)
2 Eosinophilic Esophagitis Drug Estimates and Forecasts by Region
2.1 Global Eosinophilic Esophagitis Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Eosinophilic Esophagitis Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Eosinophilic Esophagitis Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Eosinophilic Esophagitis Drug Revenue Market Share by Region (2016-2021)
2.3 Global Eosinophilic Esophagitis Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Eosinophilic Esophagitis Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Eosinophilic Esophagitis Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Eosinophilic Esophagitis Drug Estimates and Projections (2016-2027)
2.4.2 Europe Eosinophilic Esophagitis Drug Estimates and Projections (2016-2027)
2.4.3 China Eosinophilic Esophagitis Drug Estimates and Projections (2016-2027)
2.4.4 Japan Eosinophilic Esophagitis Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Eosinophilic Esophagitis Drug Estimates and Projections (2016-2027)
2.4.6 India Eosinophilic Esophagitis Drug Estimates and Projections (2016-2027)
3 Global Eosinophilic Esophagitis Drug Competition Landscape by Players
3.1 Global Top Eosinophilic Esophagitis Drug Players by Sales (2016-2021)
3.2 Global Top Eosinophilic Esophagitis Drug Players by Revenue (2016-2021)
3.3 Global Eosinophilic Esophagitis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Eosinophilic Esophagitis Drug as of 2020)
3.4 Global Eosinophilic Esophagitis Drug Average Price by Company (2016-2021)
3.5 Manufacturers Eosinophilic Esophagitis Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Eosinophilic Esophagitis Drug Market Size by Type
4.1 Global Eosinophilic Esophagitis Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Eosinophilic Esophagitis Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Eosinophilic Esophagitis Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Eosinophilic Esophagitis Drug Price by Type (2016-2021)
4.2 Global Eosinophilic Esophagitis Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Eosinophilic Esophagitis Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Eosinophilic Esophagitis Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Eosinophilic Esophagitis Drug Price Forecast by Type (2022-2027)
5 Global Eosinophilic Esophagitis Drug Market Size by Application
5.1 Global Eosinophilic Esophagitis Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Eosinophilic Esophagitis Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Eosinophilic Esophagitis Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Eosinophilic Esophagitis Drug Price by Application (2016-2021)
5.2 Global Eosinophilic Esophagitis Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Eosinophilic Esophagitis Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Eosinophilic Esophagitis Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Eosinophilic Esophagitis Drug Price Forecast by Application (2022-2027)
6 North America Eosinophilic Esophagitis Drug Market Facts & Figures
6.1 North America Eosinophilic Esophagitis Drug Sales by Company
6.1.1 North America Eosinophilic Esophagitis Drug Sales by Company (2016-2021)
6.1.2 North America Eosinophilic Esophagitis Drug Revenue by Company (2016-2021)
6.2 North America Eosinophilic Esophagitis Drug Sales Breakdown by Type
6.2.1 North America Eosinophilic Esophagitis Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Eosinophilic Esophagitis Drug Sales Breakdown by Type (2022-2027)
6.3 North America Eosinophilic Esophagitis Drug Sales Breakdown by Application
6.3.1 North America Eosinophilic Esophagitis Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Eosinophilic Esophagitis Drug Sales Breakdown by Application (2022-2027)
7 Europe Eosinophilic Esophagitis Drug Market Facts & Figures
7.1 Europe Eosinophilic Esophagitis Drug Sales by Company
7.1.1 Europe Eosinophilic Esophagitis Drug Sales by Company (2016-2021)
7.1.2 Europe Eosinophilic Esophagitis Drug Revenue by Company (2016-2021)
7.2 Europe Eosinophilic Esophagitis Drug Sales Breakdown by Type
7.2.1 Europe Eosinophilic Esophagitis Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Eosinophilic Esophagitis Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Eosinophilic Esophagitis Drug Sales Breakdown by Application
7.3.1 Europe 149 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 149 Sales Breakdown by Application (2022-2027)
8 China Eosinophilic Esophagitis Drug Market Facts & Figures
8.1 China Eosinophilic Esophagitis Drug Sales by Company
8.1.1 China Eosinophilic Esophagitis Drug Sales by Company (2016-2021)
8.1.2 China Eosinophilic Esophagitis Drug Revenue by Company (2016-2021)
8.2 China Eosinophilic Esophagitis Drug Sales Breakdown by Type
8.2.1 China Eosinophilic Esophagitis Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Eosinophilic Esophagitis Drug Sales Breakdown by Type (2022-2027)
8.3 China Eosinophilic Esophagitis Drug Sales Breakdown by Application
8.3.1 China 315 Sales Breakdown by Application (2016-2021)
8.3.2 China 315 Sales Breakdown by Application (2022-2027)
9 Japan Eosinophilic Esophagitis Drug Market Facts & Figures
9.1 Japan Eosinophilic Esophagitis Drug Sales by Company
9.1.1 Japan Eosinophilic Esophagitis Drug Sales by Company (2016-2021)
9.1.2 Japan Eosinophilic Esophagitis Drug Revenue by Company (2016-2021)
9.2 Japan Eosinophilic Esophagitis Drug Sales Breakdown by Type
9.2.1 Japan Eosinophilic Esophagitis Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Eosinophilic Esophagitis Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Eosinophilic Esophagitis Drug Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Eosinophilic Esophagitis Drug Market Facts & Figures
10.1 Southeast Asia Eosinophilic Esophagitis Drug Sales by Company
10.1.1 Southeast Asia Eosinophilic Esophagitis Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Eosinophilic Esophagitis Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Eosinophilic Esophagitis Drug Sales Breakdown by Type
10.2.1 Southeast Asia Eosinophilic Esophagitis Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Eosinophilic Esophagitis Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Eosinophilic Esophagitis Drug Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Eosinophilic Esophagitis Drug Market Facts & Figures
11.1 India Eosinophilic Esophagitis Drug Sales by Company
11.1.1 India Eosinophilic Esophagitis Drug Sales by Company (2016-2021)
11.1.2 India Eosinophilic Esophagitis Drug Revenue by Company (2016-2021)
11.2 India Eosinophilic Esophagitis Drug Sales Breakdown by Type
11.2.1 India Eosinophilic Esophagitis Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Eosinophilic Esophagitis Drug Sales Breakdown by Type (2022-2027)
11.3 India Eosinophilic Esophagitis Drug Sales Breakdown by Application
11.3.1 India Eosinophilic Esophagitis Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Eosinophilic Esophagitis Drug Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Eosinophilic Esophagitis Drug Business
12.1 AstraZeneca
12.1.1 AstraZeneca Corporation Information
12.1.2 AstraZeneca Business Overview
12.1.3 AstraZeneca Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 AstraZeneca Eosinophilic Esophagitis Drug Products Offered
12.1.5 AstraZeneca Recent Development
12.2 GSK
12.2.1 GSK Corporation Information
12.2.2 GSK Business Overview
12.2.3 GSK Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 GSK Eosinophilic Esophagitis Drug Products Offered
12.2.5 GSK Recent Development
12.3 Bayer
12.3.1 Bayer Corporation Information
12.3.2 Bayer Business Overview
12.3.3 Bayer Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Bayer Eosinophilic Esophagitis Drug Products Offered
12.3.5 Bayer Recent Development
12.4 Adare Pharmaceuticals
12.4.1 Adare Pharmaceuticals Corporation Information
12.4.2 Adare Pharmaceuticals Business Overview
12.4.3 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Products Offered
12.4.5 Adare Pharmaceuticals Recent Development
12.5 DBV Technologies
12.5.1 DBV Technologies Corporation Information
12.5.2 DBV Technologies Business Overview
12.5.3 DBV Technologies Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 DBV Technologies Eosinophilic Esophagitis Drug Products Offered
12.5.5 DBV Technologies Recent Development
12.6 Dr. Falk Pharma
12.6.1 Dr. Falk Pharma Corporation Information
12.6.2 Dr. Falk Pharma Business Overview
12.6.3 Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Dr. Falk Pharma Eosinophilic Esophagitis Drug Products Offered
12.6.5 Dr. Falk Pharma Recent Development
12.7 Quorum Innovations
12.7.1 Quorum Innovations Corporation Information
12.7.2 Quorum Innovations Business Overview
12.7.3 Quorum Innovations Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Quorum Innovations Eosinophilic Esophagitis Drug Products Offered
12.7.5 Quorum Innovations Recent Development
12.8 Takeda
12.8.1 Takeda Corporation Information
12.8.2 Takeda Business Overview
12.8.3 Takeda Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Takeda Eosinophilic Esophagitis Drug Products Offered
12.8.5 Takeda Recent Development
12.9 Calypso
12.9.1 Calypso Corporation Information
12.9.2 Calypso Business Overview
12.9.3 Calypso Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Calypso Eosinophilic Esophagitis Drug Products Offered
12.9.5 Calypso Recent Development
12.10 Celgene
12.10.1 Celgene Corporation Information
12.10.2 Celgene Business Overview
12.10.3 Celgene Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Celgene Eosinophilic Esophagitis Drug Products Offered
12.10.5 Celgene Recent Development
12.11 Regeneron
12.11.1 Regeneron Corporation Information
12.11.2 Regeneron Business Overview
12.11.3 Regeneron Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Regeneron Eosinophilic Esophagitis Drug Products Offered
12.11.5 Regeneron Recent Development
13 Eosinophilic Esophagitis Drug Manufacturing Cost Analysis
13.1 Eosinophilic Esophagitis Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Eosinophilic Esophagitis Drug
13.4 Eosinophilic Esophagitis Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Eosinophilic Esophagitis Drug Distributors List
14.3 Eosinophilic Esophagitis Drug Customers
15 Market Dynamics
15.1 Eosinophilic Esophagitis Drug Market Trends
15.2 Eosinophilic Esophagitis Drug Drivers
15.3 Eosinophilic Esophagitis Drug Market Challenges
15.4 Eosinophilic Esophagitis Drug Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Eosinophilic Esophagitis Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Eosinophilic Esophagitis Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Eosinophilic Esophagitis Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Eosinophilic Esophagitis Drug Sales (K Units) by Region (2016-2021)
Table 5. Global Eosinophilic Esophagitis Drug Sales Market Share by Region (2016-2021)
Table 6. Global Eosinophilic Esophagitis Drug Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Eosinophilic Esophagitis Drug Revenue Share by Region (2016-2021)
Table 8. Global Eosinophilic Esophagitis Drug Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Eosinophilic Esophagitis Drug Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Eosinophilic Esophagitis Drug Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Eosinophilic Esophagitis Drug Revenue Share Forecast by Region (2022-2027)
Table 12. Global Eosinophilic Esophagitis Drug Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Eosinophilic Esophagitis Drug Sales Share by Company (2016-2021)
Table 14. Global Eosinophilic Esophagitis Drug Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Eosinophilic Esophagitis Drug Revenue Share by Company (2016-2021)
Table 16. Global Eosinophilic Esophagitis Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Eosinophilic Esophagitis Drug as of 2020)
Table 17. Global Eosinophilic Esophagitis Drug Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Eosinophilic Esophagitis Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Eosinophilic Esophagitis Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Eosinophilic Esophagitis Drug Sales (K Units) by Type (2016-2021)
Table 22. Global Eosinophilic Esophagitis Drug Sales Share by Type (2016-2021)
Table 23. Global Eosinophilic Esophagitis Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Eosinophilic Esophagitis Drug Price (USD/Unit) by Type (2016-2021)
Table 25. Global Eosinophilic Esophagitis Drug Sales Share by Type (2022-2027)
Table 26. Global Eosinophilic Esophagitis Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Eosinophilic Esophagitis Drug Revenue Share by Type (2022-2027)
Table 28. Global Eosinophilic Esophagitis Drug Price (USD/Unit) by Type (2022-2027)
Table 29. Global Eosinophilic Esophagitis Drug Sales (K Units) by Application (2016-2021)
Table 30. Global Eosinophilic Esophagitis Drug Sales Share by Application (2016-2021)
Table 31. Global Eosinophilic Esophagitis Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Eosinophilic Esophagitis Drug Price (USD/Unit) by Application (2016-2021)
Table 33. Global Eosinophilic Esophagitis Drug Sales (K Units) by Application (2022-2027)
Table 34. Global Eosinophilic Esophagitis Drug Sales Share by Application (2022-2027)
Table 35. Global Eosinophilic Esophagitis Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Eosinophilic Esophagitis Drug Revenue Share by Application (2022-2027)
Table 37. Global Eosinophilic Esophagitis Drug Price (USD/Unit) by Application (2022-2027)
Table 38. North America Eosinophilic Esophagitis Drug Sales (K Units) by Company (2016-2021)
Table 39. North America Eosinophilic Esophagitis Drug Sales Market Share by Company (2016-2021)
Table 40. North America Eosinophilic Esophagitis Drug Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Eosinophilic Esophagitis Drug Revenue Market Share by Company (2016-2021)
Table 42. North America Eosinophilic Esophagitis Drug Sales by Type (2016-2021) & (K Units)
Table 43. North America Eosinophilic Esophagitis Drug Sales Market Share by Type (2016-2021)
Table 44. North America Eosinophilic Esophagitis Drug Sales by Type (2022-2027) & (K Units)
Table 45. North America Eosinophilic Esophagitis Drug Sales Market Share by Type (2022-2027)
Table 46. North America Eosinophilic Esophagitis Drug Sales by Application (2016-2021) & (K Units)
Table 47. North America Eosinophilic Esophagitis Drug Sales Market Share by Application (2016-2021)
Table 48. North America Eosinophilic Esophagitis Drug Sales by Application (2022-2027) & (K Units)
Table 49. North America Eosinophilic Esophagitis Drug Sales Market Share by Application (2022-2027)
Table 50. Europe Eosinophilic Esophagitis Drug Sales (K Units) by Company (2016-2021)
Table 51. Europe Eosinophilic Esophagitis Drug Sales Market Share by Company (2016-2021)
Table 52. Europe Eosinophilic Esophagitis Drug Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Eosinophilic Esophagitis Drug Revenue Market Share by Company (2016-2021)
Table 54. Europe Eosinophilic Esophagitis Drug Sales by Type (2016-2021) & (K Units)
Table 55. Europe Eosinophilic Esophagitis Drug Sales Market Share by Type (2016-2021)
Table 56. Europe Eosinophilic Esophagitis Drug Sales by Type (2022-2027) & (K Units)
Table 57. Europe Eosinophilic Esophagitis Drug Sales Market Share by Type (2022-2027)
Table 58. Europe Eosinophilic Esophagitis Drug Sales by Application (2016-2021) & (K Units)
Table 59. Europe Eosinophilic Esophagitis Drug Sales Market Share by Application (2016-2021)
Table 60. Europe Eosinophilic Esophagitis Drug Sales by Application (2022-2027) & (K Units)
Table 61. Europe Eosinophilic Esophagitis Drug Sales Market Share by Application (2022-2027)
Table 62. China Eosinophilic Esophagitis Drug Sales (K Units) by Company (2016-2021)
Table 63. China Eosinophilic Esophagitis Drug Sales Market Share by Company (2016-2021)
Table 64. China Eosinophilic Esophagitis Drug Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Eosinophilic Esophagitis Drug Revenue Market Share by Company (2016-2021)
Table 66. China Eosinophilic Esophagitis Drug Sales by Type (2016-2021) & (K Units)
Table 67. China Eosinophilic Esophagitis Drug Sales Market Share by Type (2016-2021)
Table 68. China Eosinophilic Esophagitis Drug Sales by Type (2022-2027) & (K Units)
Table 69. China Eosinophilic Esophagitis Drug Sales Market Share by Type (2022-2027)
Table 70. China Eosinophilic Esophagitis Drug Sales by Application (2016-2021) & (K Units)
Table 71. China Eosinophilic Esophagitis Drug Sales Market Share by Application (2016-2021)
Table 72. China Eosinophilic Esophagitis Drug Sales by Application (2022-2027) & (K Units)
Table 73. China Eosinophilic Esophagitis Drug Sales Market Share by Application (2022-2027)
Table 74. Japan Eosinophilic Esophagitis Drug Sales (K Units) by Company (2016-2021)
Table 75. Japan Eosinophilic Esophagitis Drug Sales Market Share by Company (2016-2021)
Table 76. Japan Eosinophilic Esophagitis Drug Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Eosinophilic Esophagitis Drug Revenue Market Share by Company (2016-2021)
Table 78. Japan Eosinophilic Esophagitis Drug Sales by Type (2016-2021) & (K Units)
Table 79. Japan Eosinophilic Esophagitis Drug Sales Market Share by Type (2016-2021)
Table 80. Japan Eosinophilic Esophagitis Drug Sales by Type (2022-2027) & (K Units)
Table 81. Japan Eosinophilic Esophagitis Drug Sales Market Share by Type (2022-2027)
Table 82. Japan Eosinophilic Esophagitis Drug Sales by Application (2016-2021) & (K Units)
Table 83. Japan Eosinophilic Esophagitis Drug Sales Market Share by Application (2016-2021)
Table 84. Japan Eosinophilic Esophagitis Drug Sales by Application (2022-2027) & (K Units)
Table 85. Japan Eosinophilic Esophagitis Drug Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Eosinophilic Esophagitis Drug Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Eosinophilic Esophagitis Drug Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Eosinophilic Esophagitis Drug Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Eosinophilic Esophagitis Drug Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Eosinophilic Esophagitis Drug Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Eosinophilic Esophagitis Drug Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Eosinophilic Esophagitis Drug Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Eosinophilic Esophagitis Drug Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Eosinophilic Esophagitis Drug Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Eosinophilic Esophagitis Drug Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Eosinophilic Esophagitis Drug Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Eosinophilic Esophagitis Drug Sales Market Share by Application (2022-2027)
Table 98. India Eosinophilic Esophagitis Drug Sales (K Units) by Company (2016-2021)
Table 99. India Eosinophilic Esophagitis Drug Sales Market Share by Company (2016-2021)
Table 100. India Eosinophilic Esophagitis Drug Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Eosinophilic Esophagitis Drug Revenue Market Share by Company (2016-2021)
Table 102. India Eosinophilic Esophagitis Drug Sales by Type (2016-2021) & (K Units)
Table 103. India Eosinophilic Esophagitis Drug Sales Market Share by Type (2016-2021)
Table 104. India Eosinophilic Esophagitis Drug Sales by Type (2022-2027) & (K Units)
Table 105. India Eosinophilic Esophagitis Drug Sales Market Share by Type (2022-2027)
Table 106. India Eosinophilic Esophagitis Drug Sales by Application (2016-2021) & (K Units)
Table 107. India Eosinophilic Esophagitis Drug Sales Market Share by Application (2016-2021)
Table 108. India Eosinophilic Esophagitis Drug Sales by Application (2022-2027) & (K Units)
Table 109. India Eosinophilic Esophagitis Drug Sales Market Share by Application (2022-2027)
Table 110. AstraZeneca Corporation Information
Table 111. AstraZeneca Description and Business Overview
Table 112. AstraZeneca Eosinophilic Esophagitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. AstraZeneca Eosinophilic Esophagitis Drug Product
Table 114. AstraZeneca Recent Development
Table 115. GSK Corporation Information
Table 116. GSK Description and Business Overview
Table 117. GSK Eosinophilic Esophagitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. GSK Eosinophilic Esophagitis Drug Product
Table 119. GSK Recent Development
Table 120. Bayer Corporation Information
Table 121. Bayer Description and Business Overview
Table 122. Bayer Eosinophilic Esophagitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Bayer Eosinophilic Esophagitis Drug Product
Table 124. Bayer Recent Development
Table 125. Adare Pharmaceuticals Corporation Information
Table 126. Adare Pharmaceuticals Description and Business Overview
Table 127. Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Adare Pharmaceuticals Eosinophilic Esophagitis Drug Product
Table 129. Adare Pharmaceuticals Recent Development
Table 130. DBV Technologies Corporation Information
Table 131. DBV Technologies Description and Business Overview
Table 132. DBV Technologies Eosinophilic Esophagitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. DBV Technologies Eosinophilic Esophagitis Drug Product
Table 134. DBV Technologies Recent Development
Table 135. Dr. Falk Pharma Corporation Information
Table 136. Dr. Falk Pharma Description and Business Overview
Table 137. Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Dr. Falk Pharma Eosinophilic Esophagitis Drug Product
Table 139. Dr. Falk Pharma Recent Development
Table 140. Quorum Innovations Corporation Information
Table 141. Quorum Innovations Description and Business Overview
Table 142. Quorum Innovations Eosinophilic Esophagitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Quorum Innovations Eosinophilic Esophagitis Drug Product
Table 144. Quorum Innovations Recent Development
Table 145. Takeda Corporation Information
Table 146. Takeda Eosinophilic Esophagitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Takeda Description and Business Overview
Table 148. Takeda Eosinophilic Esophagitis Drug Product
Table 149. Takeda Recent Development
Table 150. Calypso Corporation Information
Table 151. Calypso Eosinophilic Esophagitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Calypso Description and Business Overview
Table 153. Calypso Eosinophilic Esophagitis Drug Product
Table 154. Calypso Recent Development
Table 155. Celgene Corporation Information
Table 156. Celgene Description and Business Overview
Table 157. Celgene Eosinophilic Esophagitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Celgene Eosinophilic Esophagitis Drug Product
Table 159. Celgene Recent Development
Table 160. Regeneron Corporation Information
Table 161. Regeneron Description and Business Overview
Table 162. Regeneron Eosinophilic Esophagitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 163. Regeneron Eosinophilic Esophagitis Drug Product
Table 164. Regeneron Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. Eosinophilic Esophagitis Drug Distributors List
Table 168. Eosinophilic Esophagitis Drug Customers List
Table 169. Eosinophilic Esophagitis Drug Market Trends
Table 170. Eosinophilic Esophagitis Drug Market Drivers
Table 171. Eosinophilic Esophagitis Drug Market Challenges
Table 172. Eosinophilic Esophagitis Drug Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Eosinophilic Esophagitis Drug Product Picture
Figure 2. Global Eosinophilic Esophagitis Drug Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Eosinophilic Esophagitis Drug Sales Market Share by Application in 2021 & 2027
Figure 6. Hospitals Examples
Figure 7. Clinics Examples
Figure 8. Drugstore Examples
Figure 9. Global Eosinophilic Esophagitis Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Eosinophilic Esophagitis Drug Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Eosinophilic Esophagitis Drug Sales (K Units) Growth Rate (2016-2027)
Figure 12. Global Eosinophilic Esophagitis Drug Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 13. Global Eosinophilic Esophagitis Drug Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Eosinophilic Esophagitis Drug Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Eosinophilic Esophagitis Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Eosinophilic Esophagitis Drug Sales (K Units) Growth Rate (2016-2027)
Figure 17. Europe Eosinophilic Esophagitis Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Eosinophilic Esophagitis Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Eosinophilic Esophagitis Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Eosinophilic Esophagitis Drug Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Eosinophilic Esophagitis Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Eosinophilic Esophagitis Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Eosinophilic Esophagitis Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Eosinophilic Esophagitis Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Eosinophilic Esophagitis Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Eosinophilic Esophagitis Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Eosinophilic Esophagitis Drug Players Market Share by Revenue in Eosinophilic Esophagitis Drug: 2016 & 2020
Figure 28. Eosinophilic Esophagitis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Eosinophilic Esophagitis Drug Revenue Share by Type (2016-2021)
Figure 30. Global Eosinophilic Esophagitis Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Eosinophilic Esophagitis Drug Revenue Share by Application (2016-2021)
Figure 32. Global Eosinophilic Esophagitis Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Eosinophilic Esophagitis Drug Sales Market Share by Type in 2020
Figure 34. North America Eosinophilic Esophagitis Drug Sales Market Share by Application in 2020
Figure 35. Europe Eosinophilic Esophagitis Drug Sales Market Share by Type in 2020
Figure 36. Europe Eosinophilic Esophagitis Drug Sales Market Share by Application in 2020
Figure 37. China Eosinophilic Esophagitis Drug Sales Market Share by Type in 2020
Figure 38. China Eosinophilic Esophagitis Drug Sales Market Share by Application in 2020
Figure 39. Japan Eosinophilic Esophagitis Drug Sales Market Share by Type in 2020
Figure 40. Japan Eosinophilic Esophagitis Drug Sales Market Share by Application in 2020
Figure 41. Southeast Asia Eosinophilic Esophagitis Drug Sales Market Share by Type in 2020
Figure 42. Southeast Asia Eosinophilic Esophagitis Drug Sales Market Share by Application in 2020
Figure 43. India Eosinophilic Esophagitis Drug Sales Market Share by Type in 2020
Figure 44. India Eosinophilic Esophagitis Drug Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Eosinophilic Esophagitis Drug
Figure 47. Manufacturing Process Analysis of Eosinophilic Esophagitis Drug
Figure 48. Eosinophilic Esophagitis Drug Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
世界の好酸球性肉芽腫症治療市場規模・現状・予測（2021年-2027年） Eosinophilic Granulomatosis is a rare autoimmune disease usually characterized by acute asthma, vascular inflammation, and high levels of eosinophilic granulosis.Eosinophilic granulomatosis affects various organs such as the lungs, skin, gastrointestinal tract, heart, and nervous system.Eosinophilic…- 世界のスニチニブ薬市場規模・現状・予測（2021年-2027年） Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on J…
- 世界のアンブリセンタン薬市場規模・現状・予測（2021年-2027年） Ambrisentan (U.S. trade name Letairis; E.U. trade name Volibris; India trade name Pulmonext by MSN labs) is a drug indicated for use in the treatment of pulmonary hypertension. Market Analysis and Insights: Global Ambrisentan Drug Market The global Ambrisentan Drug market size is projected to reach …
- 世界の甲状腺機能低下症治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hypothyroidism Drug Market The global Hypothyroidism Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report mak…
- 世界のパルボシクリブ薬市場規模・現状・予測（2021年-2027年） Palbociclib is a drug manufactured by Pfizer, marketed under the brand Ibrance, and it is used for the treatment of hormone receptor-positive (HR+ve) and human epidermal growth factor receptor 2-negative (HER2-), advanced or metastatic breast cancer. It inhibits the activity of cyclin dependent kina…